ArticleExperimental hematology & oncology2024

TRIB3 silencing promotes the downregulation of Akt pathway and PAX3-FOXO1 in high-risk rhabdomyosarcoma.

Gabriel Gallo-Oller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.